Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.
about
Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpuraImmune thrombocytopeniaPiecing together the humoral and cellular mechanisms of immune thrombocytopeniaThe Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and PathogenesisInterleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases.The expression of IFN-gamma, IL-4, Foxp3 and perforin genes are not correlated with DNA methylation status in patients with immune thrombocytopenic purpura.Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents.Increased number of B-cells in the red pulp of the spleen in ITP.Skewed T-cell subsets and enhanced macrophages phagocytosis in the spleen of patients with immune thrombocytopenia failing glucocorticoids.Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.Increased number of Tc17 and correlation with Th17 cells in patients with immune thrombocytopenia.Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia.Defective regulatory B-cell compartment in patients with immune thrombocytopeniaCD4+ CD25+High Foxp3+ regulatory T cells, B lymphocytes, and T lymphocytes in patients with acute ITP in Assiut Children Hospital.CD16+ monocytes control T-cell subset development in immune thrombocytopenia.Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.The clinical significance of circulating B cells secreting anti-glycoprotein IIb/IIIa antibody and platelet glycoprotein IIb/IIIa in patients with primary immune thrombocytopenia.Abnormality of regulatory T-cells in remission and non-remission idiopathic thrombocytopaenic purpura patients.Reduced expression of MIR409-3p in primary immune thrombocytopenia.Immune dysregulation in immune thrombocytopenia.Pathophysiology and management of primary immune thrombocytopenia.Plasmacytoid dendritic cells, interferon signaling, and FcγR contribute to pathogenesis and therapeutic response in childhood immune thrombocytopenia.Cellular immune dysfunction in immune thrombocytopenia (ITP).Megakaryocyte morphology and its impact in predicting response to steroid in immune thrombocytopenia.Advances in immunopathogenesis of adult immune thrombocytopenia.Downregulation of T-bet/GATA-3 ratio induced by IL-11 treatment is responsible for Th1/Th2 balance restoration in human immune thrombocytopenic purpura (ITP).Elevated NKT cell levels in adults with severe chronic immune thrombocytopenia.The role of T cell immunoglobulin and mucin domain-3 in immune thrombocytopenia.Absolute lymphocyte count and risk of short-term infection in patients with immune thrombocytopenia.Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients.Immune thrombocytopenia: recent progress in pathophysiology and treatment.Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines.Reduced MIR130A is involved in primary immune thrombocytopenia via targeting TGFB1 and IL18.In vitro TNF blockade enhances ex vivo expansion of regulatory T cells in patients with immune thrombocytopeniaImmune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.Inactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia.Association of primary immune thrombocytopenia and common allergic diseases among children.Interleukin 35 may contribute to the loss of immunological self-tolerance in patients with primary immune thrombocytopenia.Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia.
P2860
Q24645016-FD9C368C-1BEF-441B-883D-277D3458EAC6Q26830918-9B1D0304-6945-4F95-9A91-82D907B9ECD6Q27024841-46086BB4-86FD-4C92-BD72-518DF14A0824Q28068881-CCC10BE3-EEAD-4CE2-A329-5BF70099EEABQ30244926-76EF5CFE-6F60-427A-98EF-3B29BCDF804EQ33387962-197C1A28-4A61-4333-A3D4-8F5E6BB6CF55Q33391221-876F5F95-E670-4A5A-A346-DCF33FCCBF6DQ33396338-0FC97CB6-1D31-4D77-B780-7D51243A0D3FQ33396799-34197677-CE4F-4D08-B8F1-AD0B1855A519Q33396902-05AF9FE3-D97E-4255-8973-B5F92EE05662Q33397882-7361DC05-99E0-40BA-A459-35E982974AD5Q33399044-8DC264B8-9A32-4A80-A839-05760E80862CQ33402659-F6831C23-20F5-4319-B313-CF8D1ABC6CFFQ33402738-1B704BA8-C705-4D52-A6B7-C4E6DEAA3B97Q33402944-93D4949C-19C7-4874-AABA-3E744FCBD28CQ33403052-3389F95F-CFD1-4167-8A77-9F805521B68BQ33403270-74610839-EE92-46EF-AF3A-936E03275F19Q33404699-A6AAE6B2-05EF-4FFB-8C29-E2561D516965Q33405565-B00C3A5D-EEA7-444A-B0A1-057E184A69DDQ33407649-A7862851-F51A-4C45-B236-DE0B9505F2D9Q33407942-FB5C9B29-FFD0-4F22-80DF-2E4EFB5EAD24Q33409032-410CE8F2-E785-44B4-9C48-FF6A2F1F7B1FQ33409710-3564F5FD-EB59-4394-A365-7DD35BA86A1FQ33411541-89F48FD1-5122-442B-87FD-77A7A314D566Q33411672-01720BE0-0E3B-4818-A657-27183578DE19Q33412108-3FEE4156-873F-45E4-8A63-1E7C9329F025Q33412177-6AC1FACC-ECFD-4D63-9C43-5B1FF36CCAD6Q33412416-3732B7CA-82A3-40A4-80BD-10A870E75DC7Q33412766-7148FE64-C871-4645-A98D-99B6AF56F0E7Q33412876-FF4ED1DB-31C2-45F9-BAB4-9D8F92DDC9AEQ33413317-B3BA14F5-69A4-4C57-A025-1CE48A93A79FQ33413896-B4E7726A-725A-4294-98C3-E18F2392DF1DQ33414858-12819C61-3BE6-48B0-A6D7-56FFE7494F16Q33415115-449E5332-1162-47D3-9FDA-78664C8BACD0Q33417826-A6B1F069-3AC8-497C-9950-4F410582D6D5Q33418883-24DC6D1E-2312-4C24-B97E-EB0D8E0E2600Q33419208-D1944DD2-C576-4887-92FD-C0EEF56DDEE1Q33419742-80D67B37-0AA6-4B90-8B63-E3E02EAE2649Q33420102-1FEBFE36-2969-4920-88EA-E6B1C3D261A1Q33422836-CE5749D0-9992-4564-B397-D89D641AD1EC
P2860
Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.
@ast
Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.
@en
type
label
Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.
@ast
Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.
@en
prefLabel
Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.
@ast
Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.
@en
P2093
P1433
P1476
Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura
@en
P2093
Hideo Wada
Isao Tawara
Miho Sakakura
Norimasa Sagawa
Takashi Sugiyama
Tsutomu Nobori
P304
P356
10.1016/J.THROMRES.2006.09.008
P577
2006-10-24T00:00:00Z